As of Sep 23
| -0.39 / -0.88%|
The 2 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 46.50, with a high estimate of 47.00 and a low estimate of 46.00. The median estimate represents a +5.71% increase from the last price of 43.99.
The current consensus among 3 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.